RESUMO
OBJECTIVE: Human colorectal cancer (CRC) is characterized by a sequence of biological events that determine its induction and progression. Gut microbiota has an important role in this multistep model of carcinogenesis, as well as constitutive activation of Signal Transducer and Activator Factors 3 (p-STAT3) and Protein Inhibitor of Activated STAT3 (PIAS3), which negatively controls STAT3. It has been reported that a liver growth factor, the Augmenter of Liver Regeneration (ALR), an anti-apoptotic, anti-metastatic factor, exerts protective/cell survival and anti-metastatic activities and has been detected highly expressed in neoplastic cells. PATIENTS AND METHODS: To evaluate, by immunohistochemistry, p-STAT3, PIAS3 and ALR expression in neoplastic human tissues from CRC patients, grouping the data in accordance with the histological alterations (G1, G2 and G3) and metastasis presence. Western blot (WB) analysis of ALR was also determined in neoplastic and surrounding tissues. Finally, cell proliferation (Ki-67) and apoptosis (Bcl-2) were determined. RESULTS: Colon cancer tissue samples showed: (1) ALR and p-STAT3 strongly over-expression in 100% of G1 tissue samples, reducing in G2 and G3 tissue samples; (2) PIAS3 immunological determination was poorly expressed in G1 tissue samples and highly expressed in the 100% of colorectal tissues from group G2 and G3. Ki-67 progressively increases with the importance of the anatomic-pathological alterations and Bcl-2 resulted higher in G3 tissue samples compared to G1 neoplastic tissues. WB data evidenced, in neoplastic tissues, compared to the tumour-surrounding tissues, ALR over-expressed in G1 neoplastic tissues and down-expressed in G3 neoplastic tissues. CONCLUSIONS: Our data demonstrate a different dynamism of the investigated factors in relation to the severity of CRC histological findings. We hypothesize that the positive expression of ALR and p-STAT3 in the neoplastic tissue samples from CRC G1 group, associated to the absence of PIAS3, could be useful marker to identify an early stage of the disease. Based on these data and on our previous studies on gut microbiota in precancerous intestinal lesions, we are confident that, after microbial priming, a cascade of molecular events is started. So, the detectable molecules acting in these initial steps should be considered for the study of CRC progression and therapy.
Assuntos
Neoplasias Colorretais/genética , Regeneração Hepática/genética , Chaperonas Moleculares/genética , Proteínas Inibidoras de STAT Ativados/genética , Fator de Transcrição STAT3/genética , Adulto , Idoso , Idoso de 80 Anos ou mais , Apoptose , Proliferação de Células , Neoplasias Colorretais/diagnóstico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Chaperonas Moleculares/análise , Proteínas Inibidoras de STAT Ativados/análise , Fator de Transcrição STAT3/análiseRESUMO
The importance of signal transducer and activator of transcription 3 (STAT3) signaling in the growth and survival of glioblastoma cells has been well documented, while the reasons leading to STAT3 activation remains to be elucidated. Suppressors of cytokine signaling (SOCS) 1 and SOCS3, SH2 domaincontaining phosphatase (SHP2) and protein inhibitors of activated STAT3 (PIAS3) are known to inhibit STAT3 signal transduction, while their expression statuses in the four grades of astrocytomas and relevance with STAT3 activation remain to be described. The present study aimed to address these issues by tissue microarraybased immunohistochemical profiling the expression levels of phosphorylated (p)STAT3, SOCS1, SOCS3, PIAS3 and pSHP2. The results revealed that pSTAT3 nuclear translocation was rarely observed in noncancerous brain tissues and its frequencies were increased in a tumor gradeassociated manner (65.2, 77.1, 81.8 and 85.7% for grade IIV, respectively). PIAS3, pSHP2, SOCS1 and SOCS3 were expressed in higher levels (++ and +++) in 63.6, 90, 87.5 and 81.8% of tumor surrounding brain tissues, which reduced to 13.1, 47.8, 33.3 and 50% in grade I, 11.4, 65.7, 58.3 and 77.1% in grade II, 9.1, 63.6, 38.1 and 31.8% in grade III and 7.1, 66.7, 30.8 and 7.1% in grade IV astrocytomas. The above results revealed that although the expression levels of SOCS1, SOCS3 and, in particular, pSHP2, tend to decrease in the four types of astrocytomas, PIAS3 downregulation is more negatively correlated with STAT3 activation in the stepwise progress of astrocytomas and would indicate an unfavorable outcome.
Assuntos
Astrocitoma/patologia , Neoplasias Encefálicas/patologia , Encéfalo/patologia , Chaperonas Moleculares/análise , Proteínas Inibidoras de STAT Ativados/análise , Proteína Tirosina Fosfatase não Receptora Tipo 11/análise , Fator de Transcrição STAT3/análise , Proteína 1 Supressora da Sinalização de Citocina/análise , Proteína 3 Supressora da Sinalização de Citocinas/análise , Astrocitoma/metabolismo , Encéfalo/metabolismo , Neoplasias Encefálicas/metabolismo , Glioblastoma/patologia , Humanos , Imuno-Histoquímica , Chaperonas Moleculares/metabolismo , Proteínas Inibidoras de STAT Ativados/metabolismo , Proteína Tirosina Fosfatase não Receptora Tipo 11/metabolismo , Fator de Transcrição STAT3/metabolismo , Proteína 1 Supressora da Sinalização de Citocina/metabolismo , Proteína 3 Supressora da Sinalização de Citocinas/metabolismoRESUMO
OBJECTIVE: Resveratrol inhibits cervical cancer (CC) cells by blocking STAT3 signaling. However, the mechanism of resveratrol-induced STAT3 inactivation remains largely unknown. SHP2, PIAS3, and SOCS3 are STAT3 negative regulators; therefore, their statuses in cervical adenocarcinoma (HeLa) and squamous cell carcinoma (SiHa and C33A) cell lines without and with resveratrol treatment and their correlation with STAT3 activation in CC specimens were investigated. METHODS: MTT and TUNEL assays were used to check the resveratrol sensitivity of CC cells, and immunocytochemical staining, Western blotting, and RT-PCR were used to analyze SHP2, PIAS3, and SOCS3 expression and the intracellular distribution of STAT3. Tissue microarray based immunohistochemical staining was performed to investigate potential correlations between SHP2, PIAS3, and SOCS3 expression and STAT3 activation. RESULTS: PIAS3 and SOCS3 were found to be weakly expressed in CC cells and upregulated by resveratrol; this was accompanied by inhibition of STAT3 signaling. The SHP2 level remained unchanged in all three cell lines after resveratrol treatment. STAT3 nuclear translocation was more frequent in adenocarcinomas and squamous cell carcinomas than that of their noncancerous counterparts. The SOCS3 level and detection rate were higher in noncancerous squamous cells (but not in glandular epithelia) compared with their cancerous counterparts. The phospho-SHP2 detection rate was similar in noncancerous and tumor tissues of squamous and glandular origins; however, PIAS3 levels were distinct. CONCLUSIONS: Of the three STAT3 negative regulators, PIAS3 correlated most negatively with STAT3 nuclear translocation and may inhibit STAT3 signaling in both histological CC subtypes. PIAS3 responsiveness may reflect greater resveratrol sensitivity and improved therapeutic outcome in CCs.
Assuntos
Adenocarcinoma/metabolismo , Antineoplásicos Fitogênicos/farmacologia , Carcinoma de Células Escamosas/metabolismo , Chaperonas Moleculares/metabolismo , Proteínas Inibidoras de STAT Ativados/metabolismo , Proteína Tirosina Fosfatase não Receptora Tipo 11/metabolismo , Fator de Transcrição STAT3/metabolismo , Estilbenos/farmacologia , Proteínas Supressoras da Sinalização de Citocina/metabolismo , Neoplasias do Colo do Útero/metabolismo , Adenocarcinoma/química , Adenocarcinoma/genética , Carcinoma de Células Escamosas/química , Carcinoma de Células Escamosas/genética , Proliferação de Células/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Ciclina D1/análise , Feminino , Expressão Gênica/efeitos dos fármacos , Células HeLa , Humanos , Proteínas Inibidoras de Apoptose/análise , Chaperonas Moleculares/análise , Chaperonas Moleculares/genética , Fosforilação , Proteínas Inibidoras de STAT Ativados/análise , Proteínas Inibidoras de STAT Ativados/genética , Proteína Tirosina Fosfatase não Receptora Tipo 11/análise , Proteína Tirosina Fosfatase não Receptora Tipo 11/genética , Proteínas Proto-Oncogênicas c-myc/análise , RNA Neoplásico/metabolismo , Resveratrol , Fator de Transcrição STAT3/análise , Fator de Transcrição STAT3/efeitos dos fármacos , Transdução de Sinais/efeitos dos fármacos , Proteína 3 Supressora da Sinalização de Citocinas , Proteínas Supressoras da Sinalização de Citocina/análise , Proteínas Supressoras da Sinalização de Citocina/genética , Survivina , Neoplasias do Colo do Útero/química , Neoplasias do Colo do Útero/genética , Fator A de Crescimento do Endotélio Vascular/análiseRESUMO
Pold2 is a subunit of the DNA polymerase δ complex, encoding a protein involved in DNA replication and repair. In this study, using a yeast two-hybrid screening technique and the common cDNA fragment of the mouse PIAS2 as a bait, Pold2 was found to interact with PIAS2. A direct interaction between Pold2 and PIAS2 was confirmed by direct yeast two-hybrid. In vivo evidence of Pold2 association with PIAS2 was obtained by co-immunoprecipitation using HEK-293 cells. Subcellular localization studies demonstrated that Pold2 and PIAS2 were partially co-localized in mammalian cells. Collectively, our results suggest that Pold2 interacts under physiological conditions with PIAS2.
Assuntos
DNA Polimerase III/metabolismo , Proteínas Inibidoras de STAT Ativados/metabolismo , Animais , DNA Polimerase III/análise , DNA Polimerase III/genética , DNA Complementar/genética , Células HEK293 , Células HeLa , Humanos , Camundongos , Proteínas Inibidoras de STAT Ativados/análise , Proteínas Inibidoras de STAT Ativados/genética , Mapeamento de Interação de Proteínas , Fator de Transcrição STAT2/metabolismo , Transfecção , Técnicas do Sistema de Duplo-HíbridoRESUMO
OBJECTIVE: PIAS3 is the endogenous inhibitor of STAT3, which has been implicated in the pathogenesis of many cancers. However, the effect of PIAS3 on human tumors remains elusive. The aim of this article is to investigate the expression of PIAS3 in gastric carcinoma and its adjacent non-tumor tissues. METHODS: Samples were taken from 30 patients with gastric cancer, which included tumor or non-tumor tissues in the excised sections. The expression of PIAS3 protein was detected by immunocytochemistry, and that of mRNA by in situ hybridization. The results were semi-quantitative analyzed by using cell count and color depth to stage. RESULTS: The expression levels of PIAS3 protein and mRNA were significantly lower in gastric cancerous tissues than in its adjacent non-tumor tissues, and had a close relation with tumor size and differentiation, but not with age, gender and lymphatic metastasis in gastric carcinoma. The more large in size and poorly in differentiation, the more low PIAS3 expression was. CONCLUSION: Loss of PIAS3 expression may be an important characteristic of gastric cancer and suggest vicious degree of the tumor.
Assuntos
Carcinoma/metabolismo , Mucosa Gástrica/metabolismo , Chaperonas Moleculares/biossíntese , Proteínas Inibidoras de STAT Ativados/biossíntese , Neoplasias Gástricas/metabolismo , Idoso , Carcinoma/química , Feminino , Humanos , Masculino , Chaperonas Moleculares/análise , Proteínas Inibidoras de STAT Ativados/análise , Estômago/química , Neoplasias Gástricas/químicaRESUMO
Combination therapy with interferon-alpha (IFNalpha) and ribavirin is the current treatment of choice for hepatitis C virus (HCV) infection. However, an important number of patients fail to respond to this therapeutic strategy. Factors determining IFN responsiveness are not well understood, and assessment of biomarkers that predict the response to IFN therapy in HCV patients is necessary. Several studies show that particular HCV proteins are able to block IFN function through interaction with important IFN-signal mediators, such as signal transducers and activators of transcription (STATs). We performed immunostaining analysis of STATs in liver tissue from IFN-responder vs. non-responder HCV patients in order to compare the expression profile of these proteins between both groups. Tissue arrays of liver biopsies were used to study the expression of STAT1, STAT2, STAT5 and PIAS1 (protein inhibitor of activated STAT1). Robust and higher expression levels of STAT1, STAT2 and STAT5 in liver tissue from HCV patients were found when compared with samples from healthy donors. However, no significant differences were observed between IFN-responder and -non-responder groups, but rather increasing levels of STAT1, STAT2 and STAT5 paralleled the degree of liver injury. Importantly, PIAS1 expression in the nucleus of most hepatocytes in HCV tissue biopsy sections, particularly of non-responder HCV patients, strongly indicated a regulatory effect on STAT1-DNA binding, likely affecting the IFN late signalling. In conclusion, our evidence indicates that intense PIAS1 nuclear staining, widely distributed in hepatocytes of infected livers, could be a good predictive factor of a defective response to IFN treatment, and a biomarker that is easily detectable by immunostaining during standard histopathological liver biopsy analysis.
Assuntos
Antivirais/uso terapêutico , Hepacivirus , Hepatite C Crônica/tratamento farmacológico , Interferon-alfa/uso terapêutico , Fígado/química , Proteínas Inibidoras de STAT Ativados/análise , Proteínas Modificadoras Pequenas Relacionadas à Ubiquitina/análise , Adolescente , Adulto , Antivirais/metabolismo , Biomarcadores/análise , Estudos de Casos e Controles , Linhagem Celular Tumoral , Núcleo Celular/química , Feminino , Fibrose , Antígenos da Hepatite C/análise , Hepatite C Crônica/genética , Hepatite C Crônica/metabolismo , Humanos , Imuno-Histoquímica , Interferon-alfa/metabolismo , Fígado/metabolismo , Fígado/patologia , Masculino , Pessoa de Meia-Idade , Proteínas Inibidoras de STAT Ativados/genética , Fator de Transcrição STAT1/análise , Fator de Transcrição STAT1/genética , Fator de Transcrição STAT2/análise , Fator de Transcrição STAT2/genética , Fator de Transcrição STAT5/análise , Fator de Transcrição STAT5/genética , Proteínas Modificadoras Pequenas Relacionadas à Ubiquitina/genética , Resultado do Tratamento , Regulação para CimaRESUMO
SOX9 is a transcription factor that harbors a HMG box and plays critical roles in developmental processes including sex determination and chondrogenesis. Currently the regulation of its molecular activity is not well characterized. In the present study, we have identified PIAS1 as a regulator for SOX9 activity. Using the GST pull-down, co-immunoprecipitation, and co-localization methods in tissue culture cells and mouse embryonic tissues, we demonstrated that SOX9 interacts with PIAS1 in vitro and in vivo. PIAS1 enhanced the SUMOylation at lysine 396 of mouse SOX9. Mutant SOX9 with a conversion of lysine 396 to arginine had a distinct nuclear localization from SOX9 with covalently attached SUMO-1. Effects of SOX9 SUMOylation on its transcriptional activity were examined by reporter assays using Vanin-1 promoter and Col11a2 enhancer constructs. The lysine 396 to arginine conversion significantly increased the reporter gene activity, while covalent attachment of SUMO-1 to SOX9 by gene fusion dramatically compromised its transcriptional activity on the reporter gene. Effects of SOX9 interaction with PIAS1 on its transcriptional activity were examined by similar reporter assays. PIAS1 was able to repress both wild type SOX9 and SUMOylation-deficient SOX9-K396R, suggesting that SOX9 SUMOylation is not absolutely required for the repression by PIAS1. However, the repression was further enhanced by exogenous SUMO-1 while SUMO-ligase-deficient PIAS1 was not able to repress SOX9 activity. Thus, PIAS1 appears to repress SOX9 activity by at least two SUMO-ligase dependent mechanisms: (1) the SUMOylation of SOX9 and (2) SUMOylation of unknown factors associated with SOX9 and/or PIAS1.
Assuntos
Proteínas de Grupo de Alta Mobilidade/antagonistas & inibidores , Proteínas de Grupo de Alta Mobilidade/metabolismo , Proteínas Inibidoras de STAT Ativados/metabolismo , Fatores de Transcrição/antagonistas & inibidores , Fatores de Transcrição/metabolismo , Ativação Transcricional , Animais , Linhagem Celular , Colágeno Tipo XI/genética , Genes Reporter , Proteínas de Grupo de Alta Mobilidade/genética , Imunoprecipitação , Camundongos , Regiões Promotoras Genéticas , Proteínas Inibidoras de STAT Ativados/análise , Proteínas Inibidoras de STAT Ativados/genética , Fatores de Transcrição SOX9 , Fatores de Transcrição/genética , Ubiquitina/metabolismoRESUMO
Functional interactions between neuroendocrine and immune systems are mediated by similar ligands and receptors, which establish a bi-directional communication that is relevant for homeostasis. We investigated herein the hypothalamus-pituitary-adrenal (HPA) axis in mice acutely infected by Trypanosoma cruzi, the causative agent of Chagas' disease. Parasites were seen in the adrenal gland, whereas T. cruzi specific PCR gene amplification product was found in both adrenal and pituitary glands of infected mice. Histological and immunohistochemical analyses of pituitary and adrenal glands of infected animals revealed several alterations including vascular stasis, upregulation of the extracellular matrix proteins fibronectin and laminin, as well as T cell and macrophage infiltration. Functionally, we detected a decrease in CRH and an increase in corticosterone contents, in hypothalamus and serum respectively. In contrast, we did not find significant changes in the amounts of ACTH in sera of infected animals, whereas the serum levels of the glucocorticoid-stimulating cytokine, IL-6 (interleukin-6), were increased as compared to controls. When we analyzed the effects of T. cruzi in ACTH-producing AtT-20 cell line, infected cultures presented lower levels of ACTH and pro-opiomelanocortin production when compared to controls. In these cells we observed a strong phosphorylation of STAT-3, together with an increased synthesis of IL-6, suppressor of cytokine signaling 3 (SOCS-3) and inhibitor of activated STAT-3 (PIAS-3), which could explain the partial blockage of ACTH production. In conclusion, our data reveal that the HPA axis is altered during acute T. cruzi infection, suggesting direct and indirect influences of the parasite in the endocrine homeostasis.
Assuntos
Doença de Chagas/fisiopatologia , Sistema Hipotálamo-Hipofisário/microbiologia , Sistema Hipófise-Suprarrenal/microbiologia , Glândulas Suprarrenais/microbiologia , Glândulas Suprarrenais/fisiologia , Hormônio Adrenocorticotrópico/análise , Hormônio Adrenocorticotrópico/metabolismo , Animais , Corticosterona/análise , Corticosterona/metabolismo , Hormônio Liberador da Corticotropina/análise , Hormônio Liberador da Corticotropina/metabolismo , Sistema Hipotálamo-Hipofisário/fisiologia , Hipotálamo/microbiologia , Hipotálamo/fisiologia , Immunoblotting , Imuno-Histoquímica , Interleucina-6/análise , Interleucina-6/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Hipófise/microbiologia , Hipófise/fisiologia , Sistema Hipófise-Suprarrenal/metabolismo , Proteínas Inibidoras de STAT Ativados/análise , Proteínas Inibidoras de STAT Ativados/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fator de Transcrição STAT3/análise , Fator de Transcrição STAT3/metabolismo , Proteína 3 Supressora da Sinalização de Citocinas , Proteínas Supressoras da Sinalização de Citocina/análise , Proteínas Supressoras da Sinalização de Citocina/metabolismo , Trypanosoma cruziRESUMO
Members of the PIAS (protein inhibitor of activated signal transducer and activator of transcription) family are negative regulators of the Janus family of tyrosine kinase (JAK)-signal transducer and activator of transcription pathway. Recently, PIAS proteins have been shown to interact with multiple signaling pathways in various cellular processes, and it has been demonstrated that PIAS and PIAS-like proteins interact with nuclear hormone receptors. In this study, we have identified a novel human PIAS-like protein, provisionally termed hZimp7, which shares a high degree of sequence similarity with hZimp10 (human zinc finger-containing, Miz1, PIAS-like protein on chromosome 10). hZimp7 (human zinc finger-containing, Miz1, PIAS-like protein on chromosome 7) possesses a molecular mass of approximately 100 kDa and contains a conserved Miz (msx-interacting zinc finger) domain, a nuclear translocation signal sequence, and a C-terminal transactivation domain. Northern blot analysis revealed that hZimp7 is predominantly expressed in testis, heart, brain, prostate, and ovary. Moreover, immunohistochemical staining of prostate tissues revealed that endogenous hZimp7 protein localizes to the nuclei of prostate epithelial cells and costains with the androgen receptor (AR). Further analysis of hZimp7 subcellular localization revealed that hZimp7 and the AR colocalize within the nucleus and form a protein complex at replication foci. Transient transfection experiments showed that hZimp7 augments the transcriptional activity of the AR and other nuclear hormone receptors. In contrast, reduction of endogenous hZimp7 protein expression by RNA interference decreased AR-mediated transcription. Finally, we determined that hZimp7 physically associates with Brg1 and BAF57, components of the ATP-dependent mammalian SWI/SNF-like BAF chromatin-remodeling complexes. The above data illustrate a potential role for hZimp7 in modulation of AR and/or other nuclear receptor-mediated transcription, possibly through alteration of chromatin structure by SWI/SNF-like BAF complexes.